Bausch Health Companies BHC
NYSE BHC
$6.16 -0.26 (-4.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Other Non Operating Income (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Other Non Operating Income came in at -$7.0 million in Q2 2026, down 103.93% year-over-year from $178.0 million in Q2 2025, and up 36.36% quarter-over-quarter from -$11.0 million in Q1 2026.

Analysis

Bausch Health Companies (BHC) Other Non Operating Income (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Other Non Operating Income across 18 years of filings, most recently posting -$7.0 million for Q2 2026.

  • In Q2 2026, Other Non Operating Income fell 103.93% year-over-year to -$7.0 million; the TTM figure through Jun 2026 stood at -$44.0 million (down 128.76% YoY), while the FY2025 annual figure was $162.0 million, up 444.68% from the prior year.
  • Other Non Operating Income came in at -$7.0 million for Q2 2026 at Bausch Health Companies, up from -$11.0 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $570.0 million in Q3 2022 to a low of -$21.0 million in Q2 2023.
  • Average Other Non Operating Income over 5 years is $65.5 million, with a median of -$7.0 million recorded in 2022.
  • Year-over-year, Other Non Operating Income jumped 4850.0% in 2022 and tumbled 2200.0% in 2024.
  • Over 5 years, Other Non Operating Income stood at $369.0 million in 2022, then tumbled by 99.73% to $1.0 million in 2023, then plunged by 2200.0% to -$21.0 million in 2024, then gained by 9.52% to -$19.0 million in 2025, then jumped by 63.16% to -$7.0 million in 2026.
  • Per Business Quant data, the three most recent Other Non Operating Income figures were -$7.0 million in Q2 2026, -$11.0 million in Q1 2026, and -$19.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.00 Mn
Mar 31, 2026 -11.00 Mn
Dec 31, 2025 -19.00 Mn
Sep 30, 2025 -7.00 Mn
Jun 30, 2025 178.00 Mn
Mar 31, 2025 -4.00 Mn
Dec 31, 2024 -21.00 Mn
Jun 30, 2024 12.00 Mn
Mar 31, 2024 -15.00 Mn
Dec 31, 2023 1.00 Mn
Sep 30, 2023 -7.00 Mn
Jun 30, 2023 -21.00 Mn
Mar 31, 2023 -10.00 Mn
Dec 31, 2022 369.00 Mn
Sep 30, 2022 570.00 Mn
Jun 30, 2022 113.00 Mn
Mar 31, 2022 -7.00 Mn
Sep 30, 2021 -12.00 Mn
Jun 30, 2021 -45.00 Mn
Mar 31, 2021 -5.00 Mn